Galiximab

Tax included
Galiximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma.
MedChemExpress 
HY-P99293

Data sheet

Size
Multiple sizes
Reactivity
CD28
Application
Cancer-programmed cell death
CAS
357613-77-5